Search
for
Sort by
Research 181–210 of 1000+
- An overview of management of drug-induced hair and nail disorders
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Current and future pharmacotherapy for alopecia areata
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Immunomodulatory Effects of Platelet-Rich Plasma (PRP) on Neuroinflammation: Insights from B92 Glial Cells Stimulated with Heat-Killed Escherichia coli
- Update: baricitinib for alopecia areata
- Therapies for onychomycosis: A systematic review and network metaanalysis of mycologic cure
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Wound Healing: A Cellular Perspective
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- JAK inhibitors in dermatology: The promise of a new drug class
- COVID-19 and Sex Differences
- The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesis
- Targeted Overexpression of the Angiogenesis Inhibitor Thrombospondin-1 in the Epidermis of Transgenic Mice Prevents Ultraviolet-B-Induced Angiogenesis and Cutaneous Photo-Damage
- Epidermal Notch1 recruits RORγ+ group 3 innate lymphoid cells to orchestrate normal skin repair
- Molecular basis of hypohidrotic ectodermal dysplasia: an update
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- What causes hidradenitis suppurativa ?—15 years after
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Studying the genetic predisposing factors in the pathogenesis of acne vulgaris
- Toxic shock syndrome: Recent developments in pathogenesis
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- A novel therapeutic paradigm for patients with extensive alopecia areata
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Immune cell regulation of the hair cycle
- New drugs under investigation for the treatment of alopecias
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream